| AASLD

In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death

Read more about In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death

Kayvan Mohkam, David Nasralla, Hynek Mergental, Xavier Muller, Andrew Butler, Wayel Jassem, Charles Imber, Diethard Monbaliu, M. Thamara P. R. Perera, Richard W. Laing, Juan Carlos García‐Valdecasas, Andreas Paul, Federica Dondero, François Cauchy, Eric Savier, Olivier Scatton, Fabien Robin, Laurent Sulpice, Petru Bucur, Ephrem Salamé, Gabriella Pittau, Marc‐Antoine Allard, Pierre Pradat, Guillaume Rossignol, Jean‐Yves Mabrut, Rutger J. Ploeg, Peter J. Friend, Darius F.

Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Read more about Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Akira Kajiwara, Hiroyuki Suzuki, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Kenta Murotani, Hironori Koga, Takuji Torimura – 2 June 2022 – In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and new embolization materials provided various options for transarterial chemoembolization (TACE), expanding the range of treatment strategies.

Sixty years of functional clotting assays in pediatric liver transplantation

Read more about Sixty years of functional clotting assays in pediatric liver transplantation

Kyle A. Soltys, George V. Mazariegos – 2 June 2022

Deceased donor liver transplantation in patients on direct oral anticoagulants at the time of transplant surgery: A case series

Read more about Deceased donor liver transplantation in patients on direct oral anticoagulants at the time of transplant surgery: A case series

David M. Salerno, Grace S. Lee‐Riddle, Seema Brar, Benjamin Samstein, Robert S. Brown,, Christine Lennon – 2 June 2022

Matthew R. D’Uva To Join AASLD As CEO

Read more about Matthew R. D’Uva To Join AASLD As CEO

The American Association for the Study of Liver Diseases (AASLD) has appointed Matthew R. D’Uva, FASAE, CAE, as its new chief...

AASLD Governance Election Update

Read more about AASLD Governance Election Update

AASLD is pleased to announce the election of new Governing Board and Foundation Board members who will begin their terms in...

Sexual Transmission Of Hepatitis C Low Among HIV-negative Men Who Have Sex With Men On PrEP

Read more about Sexual Transmission Of Hepatitis C Low Among HIV-negative Men Who Have Sex With Men On PrEP

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver...

Alarming New Study Highlights Need For Improved Access To HBV Vaccination, Testing And Treatment

Read more about Alarming New Study Highlights Need For Improved Access To HBV Vaccination, Testing And Treatment

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the...

AASLD President's Statement On 2020 Nobel Prize In Medicine

Read more about AASLD President's Statement On 2020 Nobel Prize In Medicine

Join me and the AASLD in congratulating Drs. Harvey J. Alter, Michael Houghton, and Charles M. Rice, the 2020 recipients of the...

Five Years Of Regular Aspirin Use Helps Prevent Common Liver Cancer

Read more about Five Years Of Regular Aspirin Use Helps Prevent Common Liver Cancer

Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver...

Subscribe to